On July 30, 2025, Director Yoshiaki Fujimori sold 2,901 shares of Boston Scientific (BSX), totaling $310,377. This move comes ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

When considering lead replacement, physicians should weigh the risks and benefits of extraction versus abandonment.

Boston Scientific warned of the potential for rising low-voltage shock impedance (LVSI) associated with Reliance ...

In a bullish move, RBC Capital has upped its price target on Boston Scientific from $120 to $125, signaling strong confidence ...

Boston Scientific Corp. received CE mark certification under the Medical Device Regulation for its Intracept intraosseous ...

Q2 2025 Earnings Call Transcript July 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is ...

For a moment, it appeared Boston Scientific was having a rare bumpy quarter. Executives in April had estimated tariffs would ...

Boston Scientific Corporation (NYSE:BSX) is one of Goldman Sachs’ top healthcare stock picks.

Image Source: Zacks Investment Research Impressive Value-Adding Acquisitions: Boston Scientific’s recent acquisitions have added numerous products with immense potential. The company’s recently ...

The recent Atlanta Hawks news shows the potential to snatch a key Boston Celtics veteran in free agency. Learn more about which player the Hawks are targeting.

Key Celtics Vet Predicted to Bolt Boston for Hawks originally appeared on Athlon Sports. The Atlanta Hawks could start to surround their young talent with reliable veteran players in free agency.